Publication | Open Access
Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States
12
Citations
8
References
2017
Year
Pharmaceutical manufacturers and health care payers have demonstrated interest in OBAs, and under a certain set of assumptions both may benefit.
| Year | Citations | |
|---|---|---|
Page 1
Page 1